COVID-19 Health Care Professional Resources
COVID-19 News for Health Care Professionals
Vaccine News
-
Updated (bivalent) COVID-19 vaccines authorized for children down to 6 months of age (12/8/2022)
-
Fast Facts for Health Care Providers on Bivalent COVID-19 Vaccine Boosters (11/16/2022)
-
Stakeholder Call: Updated COVID-19 Vaccine Boosters (9/2/2022)
-
FDA authorizes bivalent COVID-19 vaccines for use as a booster dose. (8/31/2022)
Therapeutics News
-
FDA and HHS/ASPR authorize additional extension to the shelf-life for specific lots of Evusheld, from 18 months to 30 months. (12/5/2022)
-
Bebtelovimab is not currently authorized in any U.S. region. (11/30/2022)
-
Risk of COVID-19 due to certain variants not neutralized by Evusheld (10/3/2022)
-
COVID-19 Therapeutics Expiration Dating Extensions
-
FDA published the refreshed Know Your Treatment Options for COVID-19 Consumer Update (5/17/2022)
-
Stakeholder Call: COVID-19 Therapeutics (1/13/2022)
Testing News
-
Upcoming - Virtual Town Hall Series - Test Development and Validation During Public Health Emergencies (12/14/2022)
-
FDA revised the emergency use authorizations (EUAs) of all COVID-19 antigen tests: Repeat or serial testing (11/1/2022)
-
FDA issued an EUA for the first over-the-counter molecular test authorized for use with saliva specimens (10/18/2022)
-
FDA updates COVID-19 test policy, encourages developers to seek traditional premarket review (9/27/2022)
-
SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests (9/14/2022)
Safety News
-
Medical Device Safety: Letters to Health Care Providers, Recalls, and Safety Communications
-
Safety Communication: Pulse Oximeter Accuracy and Limitations (9/15/2022)
-
Virtual Advisory Committee Meeting (11/1/2022): To discuss factors that may affect pulse oximeter accuracy and performance, and related topics.
-
-
Do Not Use Animal Products to Treat Humans:
-
Consumers should not use: Hand Sanitizer List
COVID-19 Emergency Use Authorizations (EUAs)
COVID-19 Therapeutics
Questions? Contact the FDA’s Division of Drug Information at 301-796-3400 or druginfo@fda.hhs.gov. Learn more about reporting adverse events.
Antiviral Drugs
-
Veklury (remdesivir)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
-
Paxlovid (nirmatrelvir co-packaged with ritonavir)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
Important Prescribing Information
-
Prescriber Patient Eligibility Screening Checklist
-
Dispensing Information for Patients with Moderate Renal Impairment
-
-
Lagevrio (molnupiravir)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
Important Safety Information
-
Checklist Tool for Prescribers
-
Monoclonal Antibodies
-
Evusheld (tixagevimab co-packaged with cilgavimab)
-
Health Care Provider Fact Sheet
-
Updated Warnings and Precautions (10/3/2022)
-
New Repeat Dosage Recommendations (6/29/2022)
-
Warning and Precaution for Risk of Cross-Hypersensitivity with COVID-19 Vaccines (5/17/2022)
-
Updated Dosage Recommendations (3/22/2022)
-
Frequently Asked Questions
-
Immune Modulators
-
Actemra (tocilizumab)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
-
Baricitinib (olumiant)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
-
Kineret (anakinra)
-
Health Care Provider Fact Sheet
-
Frequently Asked Questions
-
Convalescent Plasma
-
Health Care Provider Fact Sheet
-
Recommendations for Investigational COVID-19 Convalescent Plasma
Sedatives
-
Propofol-Lipuro 1%
-
Health Care Provider Fact Sheet
-
Renal Replacement Therapies
-
Regiocit replacement solution
-
Health Care Provider Fact Sheet
-
-
Fresenius Medical multiFiltrate/ multiBic/ multiPlus replacement solutions
-
Health Care Provider Fact Sheet
-
COVID-19 Vaccines
COVID-19 Vaccine Safety
-
Report a Vaccine Serious Adverse Event online
COVID-19 Bivalent Vaccine Boosters
-
Fast Facts for Health Care Providers on Bivalent COVID-19 Vaccine Boosters
-
FDA authorized bivalent COVID-19 vaccine boosters
-
Las dosis de refuerzos de las vacunas bivalentes contra el COVID-19
COVID-19 Tests
Test Authorizations
-
Molecular Diagnostic Tests with Emergency Use Authorization
-
Antigen Diagnostic Tests with Emergency Use Authorization
-
Serology and Other Adaptive Immune Response Tests with Emergency Use Authorization
Testing Information
-
Virtual Town Hall Series – Test Development and Validation During Public Health Emergencies
-
At-Home OTC COVID-19 Diagnostic Tests
-
SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests
-
Take steps to reduce your risk of false negative at-home COVID-19 antigen tests.
-
At-Home COVID-19 Diagnostic Tests: Frequently Asked Questions (FAQs)
Personal Protective Equipment (PPE)